Dr. Christopher Glenn Fichtner’s *Cannabinomics: The Marijuana Policy Tipping Point* provides a thought-provoking analysis of U.S. drug policy through the lens of economics, medicine, and civil rights. With data and insight, Fichtner makes a compelling case for cannabis policy reform and the public health, financial, and social benefits of ending prohibition. This book explores the roots of current drug policy myths and outlines a future path driven by science and compassion.